Amdocs (DOX) Competitors $85.33 +1.44 (+1.72%) Closing price 04:00 PM EasternExtended Trading$85.34 +0.02 (+0.02%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DOX vs. CTSH, LDOS, IT, BAH, CACI, EPAM, TDC, HCKT, UIS, and FORRShould you be buying Amdocs stock or one of its competitors? The main competitors of Amdocs include Cognizant Technology Solutions (CTSH), Leidos (LDOS), Gartner (IT), Booz Allen Hamilton (BAH), CACI International (CACI), EPAM Systems (EPAM), Teradata (TDC), The Hackett Group (HCKT), Unisys (UIS), and Forrester Research (FORR). These companies are all part of the "it consulting & other services" industry. Amdocs vs. Its Competitors Cognizant Technology Solutions Leidos Gartner Booz Allen Hamilton CACI International EPAM Systems Teradata The Hackett Group Unisys Forrester Research Cognizant Technology Solutions (NASDAQ:CTSH) and Amdocs (NASDAQ:DOX) are both computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk. Is CTSH or DOX more profitable? Amdocs has a net margin of 11.94% compared to Cognizant Technology Solutions' net margin of 11.89%. Amdocs' return on equity of 19.66% beat Cognizant Technology Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Cognizant Technology Solutions11.89% 16.77% 12.34% Amdocs 11.94%19.66%10.95% Do institutionals and insiders hold more shares of CTSH or DOX? 92.4% of Cognizant Technology Solutions shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 0.3% of Cognizant Technology Solutions shares are held by insiders. Comparatively, 15.4% of Amdocs shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is CTSH or DOX a better dividend stock? Cognizant Technology Solutions pays an annual dividend of $1.24 per share and has a dividend yield of 1.8%. Amdocs pays an annual dividend of $2.11 per share and has a dividend yield of 2.5%. Cognizant Technology Solutions pays out 25.2% of its earnings in the form of a dividend. Amdocs pays out 42.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cognizant Technology Solutions has increased its dividend for 6 consecutive years and Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has more volatility & risk, CTSH or DOX? Cognizant Technology Solutions has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Does the media favor CTSH or DOX? In the previous week, Cognizant Technology Solutions had 13 more articles in the media than Amdocs. MarketBeat recorded 26 mentions for Cognizant Technology Solutions and 13 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 1.59 beat Amdocs' score of 1.16 indicating that Cognizant Technology Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cognizant Technology Solutions 23 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive Amdocs 10 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate CTSH or DOX? Cognizant Technology Solutions presently has a consensus target price of $86.07, suggesting a potential upside of 21.99%. Amdocs has a consensus target price of $105.33, suggesting a potential upside of 23.44%. Given Amdocs' stronger consensus rating and higher probable upside, analysts plainly believe Amdocs is more favorable than Cognizant Technology Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cognizant Technology Solutions 0 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.31Amdocs 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, CTSH or DOX? Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCognizant Technology Solutions$19.74B1.75$2.24B$4.9214.34Amdocs$5.00B1.92$493.20M$4.9317.31 SummaryAmdocs beats Cognizant Technology Solutions on 10 of the 19 factors compared between the two stocks. Get Amdocs News Delivered to You Automatically Sign up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DOX vs. The Competition Export to ExcelMetricAmdocsIT Services IndustryComputer SectorNASDAQ ExchangeMarket Cap$9.63B$221.56B$31.36B$10.14BDividend Yield2.46%1.71%3.17%4.57%P/E Ratio17.3135.54439.4726.13Price / Sales1.9232.142,121.38237.23Price / Cash11.7324.2636.5859.98Price / Book2.877.497.266.29Net Income$493.20M$364.92M$807.55M$270.85M7 Day Performance0.86%5.73%3.79%4.11%1 Month Performance-1.30%8.91%6.47%8.40%1 Year Performance0.33%224.09%24,156.26%28.69% Amdocs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DOXAmdocs4.9751 of 5 stars$85.33+1.7%$105.33+23.4%-2.3%$9.63B$5.00B17.3129,058News CoveragePositive NewsCTSHCognizant Technology Solutions4.8469 of 5 stars$70.83-1.4%$86.07+21.5%-9.7%$34.57B$20.49B14.39336,800Positive NewsShort Interest ↑LDOSLeidos4.1577 of 5 stars$178.46+0.4%$183.31+2.7%+17.1%$22.90B$16.66B16.8748,000Positive NewsITGartner4.9599 of 5 stars$240.79-2.7%$369.25+53.4%-53.4%$18.24B$6.30B14.8221,044Trending NewsAnalyst ForecastBAHBooz Allen Hamilton4.9576 of 5 stars$104.34-2.3%$134.00+28.4%-32.5%$12.86B$11.96B12.8235,800Positive NewsCACICACI International3.1686 of 5 stars$460.77-1.9%$549.69+19.3%+3.1%$10.13B$8.63B20.6225,000News CoverageEPAMEPAM Systems4.8173 of 5 stars$168.79-3.0%$226.25+34.0%-26.0%$9.40B$4.73B24.0861,200News CoveragePositive NewsAnalyst ForecastTDCTeradata3.8973 of 5 stars$20.36-1.7%$26.86+31.9%-23.7%$1.92B$1.68B18.015,700Trending NewsAnalyst DowngradeAnalyst RevisionHCKTThe Hackett Group4.3492 of 5 stars$20.39+0.1%$29.67+45.5%-19.3%$560.02M$313.86M33.931,180UISUnisys4.8782 of 5 stars$3.78-1.2%$7.17+89.4%-29.3%$269.76M$2.01B-3.2115,900News CoverageShort Interest ↓FORRForrester Research4.3804 of 5 stars$9.59-0.4%N/A-46.3%$182.69M$432.47M-2.041,571Positive News Related Companies and Tools Related Companies Cognizant Technology Solutions Competitors Leidos Competitors Gartner Competitors Booz Allen Hamilton Competitors CACI International Competitors EPAM Systems Competitors Teradata Competitors The Hackett Group Competitors Unisys Competitors Forrester Research Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DOX) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amdocs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Amdocs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DOX Stock Alerts